Exploration of potential prodrug approach of the bis-thiazolium salts T3 and T4 for orally delivered antimalarials |
| |
Authors: | Sergio A Caldarelli Michel Boisbrun Karine Alarcon Abdallah Hamzé Mahama Ouattara Xavier Salom-Roig Marjorie Maynadier Sharon Wein Suzanne Peyrottes Alain Pellet Michèle Calas Henri Vial |
| |
Institution: | 1. Institut des Biomolécules Max Mousseron (IBMM), UMR 5247 CNRS, Université Montpellier 2, Place Eugène Bataillon, 34095 Montpellier Cedex 5, France;2. Dynamique des Interactions Membranaires Normales et Pathologiques, CNRS UMR 5235, Université de Montpellier 2, CC 107, Place Eugène Bataillon, 34095 Montpellier Cedex 5, France;3. Sanofi-Aventis, Research & Development, 195 route d’Espagne, BP 13669, 31036 Toulouse Cedex 1, France |
| |
Abstract: | We report here the synthesis and biological evaluation of a series of 37 compounds as precursors of potent antimalarial bis-thiazolium salts (T3 and T4). These prodrugs were either thioester, thiocarbonate or thiocarbamate type and were synthesized in one step by reaction of an alkaline solution of the parent drug with the appropriate activated acyl group. Structural variations affecting physicochemical properties were made in order to improve oral activity. Twenty-five of them exhibited potent antimalarial activity with IC50 lower than 7 nM against Plasmodium falciparum in vitro. Notably, 3 and 22 showed IC50 = 2.2 and 1.8 nM, respectively. After oral administration 22 was the most potent compound clearing the parasitemia in Plasmodium vinckei infected mice with a dose of 1.3 mg/kg. |
| |
Keywords: | |
本文献已被 ScienceDirect 等数据库收录! |
|